
Another crucial coronavirus mystery was just explained
Synairgen’s SNG001 is a nebulizer containing interferon beta-1a that showed great promise in a recent Phase 2 trial. Volunteers who received the drug had greater odds of recovering from COVID-19 than placebo controls. The study did highlight a potential issue with the interferon therapy, as researchers found the drug favors the development of the kind …